Table 2.
Core Domain | Core outcome used in research | Reported previous SR |
Reported update SR |
||
---|---|---|---|---|---|
N | % | n | % | ||
Anatomy of skin | Size of CMN | 1/63 | 2 | 3/29 | 10 |
Colour of the CMN | 31/63 | 49 | 5/29 | 17 | |
Texture of the CMN | 21/63 | 33 | 3/29 | 10 | |
Satellite nevi number | 10/63 | 16 | 0/29 | 0 | |
Quality of life | Emotional distress | 6/63 | 10 | 7/29 | 24 |
Neoplasm | Presence of melanoma | 21/63 | 33 | 14/29 | 48 |
Nervous system | Neurological symptoms and signs | 11/63 | 17 | 5/29 | 17 |
General adverse events | Wound problems of the CMN | 32/63 | 51 | 11/29 | 38 |
Scar problems | 10/63 | 16 | 12/29 | 41 | |
Pathology | Molecular characteristics | 2/63 | 3 | 7/29 | 26 |
n: number of studies reporting the outcome; SR: systematic review